Chen Yu-Yen, Lai Yun-Ju, Yen Yung-Feng, Shen Ying-Cheng, Wang Chun-Yuan, Liang Chiao-Ying, Lin Keng-Hung, Fan Lir-Wan
Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan.
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
BMJ Open. 2018 Nov 5;8(11):e022987. doi: 10.1136/bmjopen-2018-022987.
To investigate a possible association between normal tension glaucoma (NTG) and an increased risk of developing Alzheimer's disease (AD).
Retrospective cohort study.
NTG group and the comparison group were retrieved from the whole population of the Taiwan National Health Insurance Research Database from 1 January 2001 to 31 December 2013.
A total of 15 317 subjects with NTG were enrolled in the NTG group, and 61 268 age-matched and gender-matched subjects without glaucoma were enrolled in the comparison group.
Kaplan-Meier curves were generated to compare the cumulative hazard of AD between the two groups. A multivariable Cox regression analysis was used to estimate the adjusted hazard ratios (HRs) of AD, adjusted for diabetes, hypertension, hyperlipidaemia, coronary artery disease and stroke. Furthermore, risk factors for developing AD among the NTG group were investigated.
The mean age of the cohort was 62.1±12.5 years. Patients with NTG had significantly higher proportions of diabetes, hypertension, hyperlipidaemia, coronary artery disease and stroke than the comparisons. Patients with NTG had a significantly higher cumulative hazard for AD than the comparisons (p<0.0001). In the multivariable Cox regression after adjustment for confounders, the NTG group had a significantly higher risk of AD (adjusted HR 1.52; 95% CI 1.41 to 1.63). Moreover, in the NTG group, when we compared the effects of different types of glaucoma eye drops, none of the eye drops used were significant risk factors or protective factors for AD.
People with NTG are at a significantly greater risk of developing AD compared with individuals without glaucoma. Among patients with NTG, none of the glaucoma eye drops used significantly changed the risk of subsequent AD.
探讨正常眼压性青光眼(NTG)与患阿尔茨海默病(AD)风险增加之间的可能关联。
回顾性队列研究。
NTG组和对照组取自2001年1月1日至2013年12月31日台湾全民健康保险研究数据库的全体人群。
NTG组共纳入15317例NTG患者,对照组纳入61268例年龄和性别匹配的无青光眼患者。
绘制Kaplan-Meier曲线以比较两组之间AD的累积风险。采用多变量Cox回归分析估计AD的调整风险比(HR),并对糖尿病、高血压、高脂血症、冠状动脉疾病和中风进行校正。此外,还研究了NTG组中发生AD的危险因素。
队列的平均年龄为62.1±12.5岁。NTG患者的糖尿病、高血压、高脂血症、冠状动脉疾病和中风的比例显著高于对照组。NTG患者发生AD的累积风险显著高于对照组(p<0.0001)。在对混杂因素进行调整后的多变量Cox回归中,NTG组发生AD的风险显著更高(调整后HR 1.52;95%CI 1.41至1.63)。此外,在NTG组中,当我们比较不同类型青光眼滴眼液的效果时,所使用的滴眼液均不是AD的显著危险因素或保护因素。
与无青光眼的个体相比,NTG患者患AD的风险显著更高。在NTG患者中,所使用的青光眼滴眼液均未显著改变后续发生AD的风险。